86.0 A

KPV

Also known as: Lys-Pro-Val

Strong Clinical Evidence Research Chemical
Research Evidence 92.0/100
Safety Profile 80.0/100

50 Clinical Trials

Unknown: 2 PHASE4: 1 PHASE3: 14 PHASE2: 5 PHASE1, PHASE2: 1 PHASE1: 1 NA: 26

Showing 5 of 50 trials.

19 Research Papers

Showing 5 of 19 papers by citation count.

FDA Data

Not FDA-Approved

KPV has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.

Frequently Asked Questions

Is KPV FDA approved?
No, KPV has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has KPV been studied in?
KPV has been studied in 50 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for KPV?
KPV has a CheckPeptides trust score of 86.0/100 (grade: A). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026

Quick Facts

Classification
Alpha-MSH fragment
Regulatory Status
N/A

Score Breakdown

Research Evidence 92.0/100
Safety Profile 80.0/100

Evidence Summary

Clinical Trials
50
Research Papers
19
Trust Score
86.0/100
Grade
A

Compare Peptides

See how KPV stacks up against similar peptides.

View Comparisons
← Browse all peptides